Valuation: Camlin Fine Sciences Limited

Market Cap 1.61TCr 17Cr 15Cr 14Cr 13Cr 24Cr 24Cr 166.88Cr 67Cr 849.11Cr 64Cr 62Cr 2.68TCr P/E 2027 *
21x
P/E 2028 * 10.4x
Enterprise Value 1.61TCr 17Cr 15Cr 14Cr 13Cr 24Cr 24Cr 166.88Cr 67Cr 849.11Cr 64Cr 62Cr 2.68TCr EV / Sales 2027 *
0.76x
EV / Sales 2028 * 0.66x
Free-Float
55.67%
Yield 2027 *
-
Yield 2028 * -
1 day+2.06%
1 week+0.49%
Current month-9.67%
1 month-9.87%
3 months-34.92%
6 months-31.65%
Current year-43.34%
1 week 79.01
Extreme 79.01
85.95
1 month 79
Extreme 79
98
Current year 79
Extreme 79
192
1 year 79
Extreme 79
202.55
3 years 79
Extreme 79
334.7
5 years 79
Extreme 79
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 01/06/2021
Director of Finance/CFO - 18/08/2026
Director TitleAgeSince
Director/Board Member 60 04/08/2014
Chairman 63 17/06/2021
Director/Board Member 60 13/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/24
Infinity Holdings
SellCompany 13,38,600 0.7992%
09/09/24
Infinity Holdings
SellCompany 6,63,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%+0.49%-58.37%-43.42% 17Cr
+0.70%+3.65%+17.68%+92.44% 8.43TCr
+1.46%-0.05%+18.88%+31.30% 4.37TCr
+0.42%-2.93%+13.28%-16.35% 3.46TCr
+1.86%+1.70%+13.13%+19.15% 3.37TCr
-0.71%-3.55%+20.53%+50.54% 3.24TCr
+0.75%+2.94%-0.62%+26.26% 2.63TCr
-0.12%-4.58%+51.76%+38.20% 2.39TCr
-0.38%+3.66%-43.18%-35.30% 1.9TCr
-3.05%-3.05%+18.62%+6.97% 1.61TCr
Average +0.30%-0.47%+5.17%+16.98% 3.14TCr
Weighted average by Cap. +0.44%-0.01%+14.56%+37.93%

Financials

2027 *2028 *
Net sales 2.13TCr 22Cr 20Cr 19Cr 17Cr 31Cr 32Cr 220.48Cr 88Cr 1.12TCr 84Cr 83Cr 3.54TCr 2.44TCr 26Cr 23Cr 21Cr 19Cr 36Cr 36Cr 251.7Cr 100.74Cr 1.28TCr 96Cr 94Cr 4.04TCr
Net income 76Cr 80.58L 72.12L 66.47L 60.16L 1.13Cr 1.15Cr 7.91Cr 3.16Cr 40Cr 3.02Cr 2.96Cr 126.95Cr 155.5Cr 1.64Cr 1.47Cr 1.35Cr 1.22Cr 2.29Cr 2.33Cr 16Cr 6.43Cr 82Cr 6.15Cr 6.02Cr 258.04Cr
Net Debt - -
Projected Income Statement - Annual - Camlin Fine Sciences Limited
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
674
Date Price Change Volume
30/26/30 ₹84.05 +2.06% 1,51,426
29/26/29 ₹82.35 -1.96% 22,594
28/26/28 ₹84.00 +0.17% 50,404
27/26/27 ₹83.86 +0.60% 14,858
26/26/26 ₹83.36 +3.73% 96,858
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Camlin Fine Sciences Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
84.05INR
Average target price
152.50INR
Spread / Average Target
+81.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camlin Fine Sciences Limited
  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock